Malignant hematologic diseases in adolescents and young adults.

  title={Malignant hematologic diseases in adolescents and young adults.},
  author={William Allen Wood and Stephanie J Lee},
  volume={117 22},
Adolescents and young adults (AYA) with cancer have been designated as a vulnerable population by the National Cancer Institute. This group, defined by the ages of 16-39 years, has not enjoyed the same survival improvements over the past several decades as older and younger cohorts. Several barriers prevent the optimal delivery of oncologic care in this subpopulation. This review will describe these challenges in the context of the major hematologic malignancies affecting this population (acute… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS
30 Citations
152 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 30 extracted citations


Publications referenced by this paper.
Showing 1-10 of 152 references

A pediatric treatment of Ph-negative Acute lymphoblastic leukemia (ALL) is effective and safe in adolescents and young adults (AYAs) until 29 years of age

  • T Cluzeau, N Dhedin, F Huguet
  • Blood (ASH Annual Meeting Abstracts)
  • 2010

Adolescent and young adult patients treated with modified augmented Berlin-Frankfurt-Muenster therapy

  • ME Rytting, HM Kantarjian, DA Thomas
  • Blood (ASH Annual Meeting Abstracts)
  • 2010

Similar Papers

Loading similar papers…